RxDoctor Payments Data

Cayley Burtis, PA

Physician Assistant · Marion, ILNPI 1043889553

Payments from drug & device makers

$3,710in general payments, 2019–2025

Across 218 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$651
  • Neurocrine Biosciences, Inc.$526
  • Otsuka America Pharmaceutical, Inc.$425
  • Alkermes, Inc.$400
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$251
  • Johnson & Johnson$231
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,68299%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,710 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$2,201
Medicare patients
20
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate23$189,853
Invega SustennaPaliperidone Palmitate46$150,582
VraylarCariprazine Hcl40$54,941
TrintellixVortioxetine Hydrobromide38$24,346
VivitrolNaltrexone Microspheres14$21,358
RexultiBrexpiprazole14$19,826
Lurasidone Hcl20$19,711
Aripiprazole72$11,199
Paliperidone ErPaliperidone53$8,741
BelsomraSuvorexant19$8,463
LinzessLinaclotide13$6,613
Olanzapine181$2,964
Quetiapine Fumarate ErQuetiapine Fumarate42$2,655
Armodafinil28$2,460
Divalproex Sodium ErDivalproex Sodium71$2,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$526$189,85323 claims
Johnson & JohnsonInvega Sustenna$231$150,58246 claims
AbbVieVraylar, Linzess$651$61,55553 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$83$24,34638 claims
Alkermes, Inc.Vivitrol$400$21,35814 claims
Otsuka America Pharmaceutical, Inc.Rexulti$425$19,82614 claims
Almatica Pharma LLCSertraline Hcl$47$762169 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Marion

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →